Original ArticlesEstrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer
Introduction
Schistosomiasis is one of the major neglected tropical diseases and it is considered the most important helminthic disease of humanity in terms of morbidity and mortality. More than 90% of the cases occur in Africa, of which about two-thirds are caused by Schistosoma haematobium [1], [2], [3], [4], [5]. Indeed, the number of cases of infection with S. haematobium may far exceed that previously predicted so that urogenital schistosomiasis (UGS) may represent the most common infection or even adverse health condition in sub-Saharan Africa [6]. In addition, female genital schistosomiasis increases the risk of transmission of HIV [7], [8], [9], and a recent outbreak in Corsica confirms its re-emergence in Europe [10], [11]. Many cases of UGS result ostensibly in only mild symptoms and disease such as hematuria, dysuria, anemia and inflammation of the genital-urinary tract [6], [12], [13], [14], [15], [16]. However, between 25 and 50% of the UGS cases experience moderate to severe morbidity [6], including renal dysfunction, obstruction of the ureters, and squamous cell carcinoma of the urinary bladder [17], [18], [19], [20]. Bladder cancer is a frequent and dire complication of chronic UGS. Case reports indicate that patients with schistosomiasis may develop bladder cancer earlier than uninfected people. The severity and frequency of the sequelae of UGS and of its complications are related to the intensity and duration of the infection [21], [22], [23]. Moreover, infection with S. haematobium is classified as a Group 1 biological carcinogen by the World Health Organization (WHO)'s International Agency for Research on Cancer (WHO IARC) [24] although the cellular and/or molecular mechanisms linking S. haematobium infection with carcinogenesis have yet to be defined [25], [26]. It has been known for several decades that bladder cancer, especially squamous cell carcinoma (SCC), a distinctly malignant, poorly differentiated neuroendocrine neoplasm [16], was geographically associated with UGS, i.e. areas endemic for schistosomiasis haematobia [20], [24], [27]. In regions with high worm burdens, and a high risk of exposure to S. haematobium infection, SCC is the most frequent histological type, whereas urothelial cell carcinoma (UCC) is predominant in non-endemic locations [22], [23], [24], [26], [28], [29].
An estrogen-DNA adduct mediated pathway in S. haematobium-infection associated bladder cancer has been postulated [27], [30], [31]. We have identified and characterized by liquid chromatography-mass spectrometry (LC-MS/MS) novel estrogen-like metabolites, present in the lysates and secretions of S. haematobium worms and eggs [27], and in sera of UGS cases [30]. Moreover, lysates of S. haematobium induce tumor-like phenotypes; Chinese Hamster Ovary cells exposed in vitro to the lysates exhibit marked proliferation and induce sarcoma formation when inoculated into nude mice. Additionally, the cells display increased duration of S phase, decreased apoptosis, down-regulation of the p27 tumor suppressor, and up-regulation of anti-apoptotic protein Bcl-2 [25], [27], [30], [31]. Eggs of S. haematobium stimulate cellular proliferation, interfere with apoptosis, increase oxidative stress, and induce a genotoxicity on HCV-29 cells, derived from human urothelial cells [27], [30], [31], [32], [33]. In addition, 8-nitroguanine forms via inducible expression of nitric oxide synthase in Oct3/4-positive stem cells in UGS-associated bladder cancer tissue [34], and DNA nitrative and oxidative mutations characterized by 8-nitroguanine and 8-hydroxy-2′-deoxyguanosine (8-oxodG), have been implicated in the promotion of inflammation-mediated carcinogenesis by infection with S. haematobium [35].
Here we undertook analysis of urine from persons with urogenital schistosomiasis (UGS) living in endemic areas in Angola. Liquid chromatography diode array detection electron spray ionization mass spectrometry (LC-ESI-MS) revealed the presence of numerous estrogen metabolites in the urine of the study participants. Seven of these molecules were specifically identified in urine of the UGS cases but, notably, were not described in the recently reported metabolome of urine from healthy humans [36]. These metabolites were potentially reactive with host DNA: the molecules were either catechol estrogen quinone (CEQ) derivatives or CEQ-DNA-adducts. In addition, novel molecules derived from 8-oxodG during UGS were also identified.
Section snippets
Ethics statement
Informed consent was obtained directly from all participants or parents of underaged participants. Clinical-pathological information was obtained from clinical records of the participants. The Ethics Committee of Agostinho Neto University, Luanda, Angola, approved all procedures employed in this investigation.
Participants assigned to three categories
The participants were assigned to three groups: Group I included cases with urogenital schistosomiasis (UGS) and squamous cell carcinoma of the bladder (SCC); Group II included cases with
Urine estrogen-derived metabolites specifically related to squamous cell carcinoma of the bladder induced by urogenital schistosomiasis
Photo diode array (PDA) detector chromatograms of the UV spectra were obtained from urine. Mass spectral analysis was undertaken in negative mode, i.e. species were detected as [M-H] ions of the main constituents of urine from Groups I, II and III. The PDA chromatograms for each of the 40 urines are presented in Supplementary Fig. S1. Notable differences among the groups of participants were apparent. Seven specific peaks occurred consistently in urine of all participants with UGS (i.e.
Discussion
Cancer of the urinary bladder is a major complication associated with chronic infection with Schistosoma haematobium in Africa and the Middle East [22], [24], [45], [46]. Genetic alterations, chromosomal aberrations, and cytological changes have been described in carcinomas associated with UGS [22], [24], [47]. N-nitroso compounds are implicated as candidate etiologic agents in the process of bladder carcinogenesis [48]. Elevated levels of DNA alkylation damage in carcinomas associated with UGS
Conflict of interest
The authors declare no conflicts of interest in preparing this article.
Acknowledgements
NV thanks Fundação para a Ciência e Tecnologia (FCT, Portugal) and FEDER (European Union) for funding through project grants CONC-REEQ/275/QUI and PEst-C/QUI/UI0081/2011. NV also thanks FCT for Post-Doc grant SFRH/BPD/48345/2008. JMCC thanks also FCT for Pest-OE/AGR/UI0211/2011 and Strategic Project UI211. PJB and GR received support from awards R01CA155297 and R01CA164719 from the National Cancer Institute (NCI). The content is solely the responsibility of the authors and does not necessarily
References (57)
- et al.
Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa
Acta Trop
(2003) - et al.
Human schistosomiasis
Lancet
(2014) - et al.
Reassessment of the cost of chronic helminth infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis
Lancet
(2005) - et al.
A review of female genital schistosomiasis
Trends Parasitol
(2012) - et al.
Human schistosomiasis: an emerging threat for Europe
Lancet
(2014) - et al.
Haematuria and proteinuria during Schistosoma haematobium infection: relationship to intensity of infection and the value of chemical reagent strips for pre- and post-treatment diagnosis
Trans. R. Soc. Trop. Med. Hyg
(1987) - et al.
The significance of proteinuria and haematuria in Schistosoma haematobium infection
Trans. R. Soc. Trop. Med. Hyg
(1979) - et al.
Association of bacteriuria and urinary nitrosamine formation with Schistosoma haematobium infection in Qalyub area of Egypt
Trans. R. Soc. Trop. Med. Hyg
(1982) - et al.
Mechanisms linking pathogens-associated inflammation and cancer
Cancer Lett
(2011) - et al.
Schistosoma haematobium total antigen induces increased proliferation, migration and invasion, and decreases apoptosis of normal epithelial cells
Int. J. Parasitol
(2009)
Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer
Trends Parasitol
Tumor-like phenotypes in urothelial cells after exposure to antigens from eggs of Schistosoma haematobium: an oestrogen-DNA adducts mediated pathway?
Int. J. Parasitol
Schistosoma haematobium: identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactive estrogen receptor in mammalian cells
Exp. Parasitol
Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium
Urol. Oncol
Schistosoma haematobium and Schistosomiasis mansoni: production of an estradiol-related compound detected by ELISA
Exp. Parasitol
Purification of urine for quantification of the complete estrogen profile
J. Steroid Biochem
Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention
Biochim. Biophys. Acta
Reactive nitrogen species in the chemical biology inflammation
Arch. Biochem. Biophys
Molecular and genetic events in schistosomiasis-associated human bladder cancer: role of oncogenes and tumor suppressor genes
Cancer Lett
Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer
J. Steroid Biochem. Mol. Biol
The molecular etiology and prevention of estrogen-initiated cancers: Ochkham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity
Mol. Aspects Med
Immunity, inflammation and cancer
Cell
Break out: urogenital schistosomiasis and Schistosoma haematobium infection in the post-genomic era
PLoS Negl. Trop. Dis
Helminth infections: the great neglected tropical diseases
J. Clin. Invest
Helminth genomics: the implications for human health
PLoS Negl. Trop. Dis
Genital schistosomiasis and its unacknowledged role on HIV transmission in the STD intervention studies
Int. J. STD AIDS
Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract
PLoS ONE
Schistosoma haematobium infections acquired in Corsica, France, August 2013
Eurosurveill
Cited by (53)
Estrogen receptors in urogenital schistosomiasis and bladder cancer: Estrogen receptor alpha-mediated cell proliferation
2020, Urologic Oncology: Seminars and Original InvestigationsCitation Excerpt :Estradiol-like metabolites have been previously described in the urine of patients with S. haematobium infection and absent from healthy humans’ urine metabolome [6,28]. We used publicly available data of these metabolites [6] to investigate their ability to interact with the ERα ligand-binding domain to yield and active state. The molecular recognition studies comprised the generation of complexes between the ERα and the M03, M08, M09 and M10 (sketched in Scheme 1) metabolites by docking, followed by the evaluation of their stability in water by MD simulations.
The microbiome and cancer for clinicians
2019, Critical Reviews in Oncology/HematologyCancerogenic parasites in veterinary medicine: a narrative literature review
2023, Infectious Agents and CancerMetabolome in urology practices: Signatures in plasma and urine
2023, Metabolomics and Clinical Approach